Loading...
Keywords
Last Name
Institution
 Back to Profile

Jay Portnoy

Concepts (535)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
65
2023
157
16.150
 Why?
Telemedicine
25
2023
59
13.710
 Why?
Hypersensitivity
47
2024
56
13.590
 Why?
Allergens
56
2023
58
8.880
 Why?
Humans
196
2024
6896
6.180
 Why?
Fungi
18
2019
20
4.900
 Why?
Environmental Exposure
21
2019
29
4.280
 Why?
Air Pollution, Indoor
20
2023
21
3.970
 Why?
Anaphylaxis
9
2024
10
3.620
 Why?
Artificial Intelligence
5
2024
14
3.150
 Why?
Food Hypersensitivity
9
2021
18
3.000
 Why?
Peanut Hypersensitivity
6
2023
7
2.850
 Why?
Allergy and Immunology
11
2022
11
2.830
 Why?
Adrenal Cortex Hormones
10
2021
37
2.810
 Why?
Desensitization, Immunologic
18
2023
20
2.550
 Why?
Pollen
10
2019
10
2.330
 Why?
Child
57
2023
3364
2.220
 Why?
Anti-Asthmatic Agents
7
2023
11
2.190
 Why?
Air Pollutants
10
2023
12
2.160
 Why?
Rhinitis, Allergic
5
2023
10
2.090
 Why?
Rhinitis, Allergic, Seasonal
15
2019
15
2.090
 Why?
Pandemics
8
2023
82
1.950
 Why?
Practice Guidelines as Topic
18
2020
108
1.950
 Why?
Epinephrine
6
2024
7
1.490
 Why?
Hypersensitivity, Immediate
7
2013
7
1.460
 Why?
Arachis
5
2023
5
1.400
 Why?
Child, Preschool
31
2022
1569
1.380
 Why?
United States
17
2019
669
1.340
 Why?
Immunoglobulin E
15
2023
22
1.330
 Why?
Delivery of Health Care
4
2023
33
1.280
 Why?
Adolescent
33
2023
2197
1.280
 Why?
Patient Education as Topic
13
2019
53
1.250
 Why?
Alternaria
12
2014
12
1.240
 Why?
Female
36
2020
3525
1.210
 Why?
Immunotherapy
7
2022
16
1.210
 Why?
Algorithms
7
2024
105
1.180
 Why?
Skin Tests
16
2020
19
1.150
 Why?
Male
34
2020
3337
1.150
 Why?
Pediatrics
2
2019
186
1.140
 Why?
Environmental Monitoring
6
2013
7
1.120
 Why?
Patient Satisfaction
7
2022
38
1.110
 Why?
Animals
20
2017
729
1.110
 Why?
Monitoring, Physiologic
3
2023
23
1.080
 Why?
Rhinitis, Allergic, Perennial
8
2013
10
1.060
 Why?
Coronavirus Infections
3
2020
15
1.050
 Why?
Pneumonia, Viral
3
2020
16
1.050
 Why?
Dust
9
2016
9
1.010
 Why?
Diagnostic Tests, Routine
2
2021
19
0.980
 Why?
Machine Learning
1
2024
17
0.960
 Why?
Spores
6
2006
6
0.930
 Why?
Health Services Accessibility
3
2019
39
0.930
 Why?
Bayes Theorem
2
2021
30
0.910
 Why?
Housing
8
2017
11
0.900
 Why?
Air Microbiology
5
2017
5
0.890
 Why?
Authorship
1
2023
3
0.890
 Why?
Stachybotrys
4
2017
4
0.880
 Why?
Remote Consultation
2
2020
4
0.860
 Why?
Bronchodilator Agents
4
2019
11
0.860
 Why?
Fungal Proteins
7
2013
10
0.850
 Why?
Histamine Antagonists
4
2020
8
0.840
 Why?
Antigens, Dermatophagoides
3
2013
3
0.830
 Why?
Adrenergic beta-Agonists
2
2014
5
0.820
 Why?
Physicians
1
2022
23
0.820
 Why?
Rural Population
2
2019
42
0.820
 Why?
Spores, Fungal
7
2019
7
0.810
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2022
39
0.800
 Why?
Likelihood Functions
2
2020
6
0.790
 Why?
Antigens, Fungal
9
2017
10
0.790
 Why?
Health Personnel
2
2020
25
0.750
 Why?
Cell Count
2
2019
16
0.740
 Why?
Self Care
3
2017
22
0.740
 Why?
Evidence-Based Medicine
9
2020
48
0.740
 Why?
Mycotoxins
3
2017
3
0.740
 Why?
Immunity, Innate
3
2017
16
0.730
 Why?
Specialization
2
2019
7
0.720
 Why?
Sublingual Immunotherapy
2
2017
2
0.720
 Why?
Drug Hypersensitivity
3
2019
19
0.710
 Why?
Disease Management
6
2019
34
0.690
 Why?
Latex Hypersensitivity
2
2019
2
0.690
 Why?
Insect Bites and Stings
7
2019
7
0.680
 Why?
Education, Medical
1
2019
3
0.680
 Why?
Education, Distance
1
2019
6
0.670
 Why?
Injections, Intramuscular
1
2019
5
0.670
 Why?
Pyroglyphidae
3
2013
3
0.660
 Why?
Environmental Restoration and Remediation
2
2009
2
0.640
 Why?
Disinfectants
2
2008
2
0.640
 Why?
Sodium Hypochlorite
2
2008
2
0.640
 Why?
Angioedema
2
2015
2
0.640
 Why?
Cockroaches
3
2013
3
0.610
 Why?
Peptides
2
2015
11
0.600
 Why?
Drug Approval
2
2019
2
0.590
 Why?
Diet Therapy
2
2016
3
0.580
 Why?
Smartphone
1
2017
6
0.580
 Why?
Antibodies, Anti-Idiotypic
2
2015
3
0.570
 Why?
Models, Theoretical
2
2015
13
0.560
 Why?
Administration, Oral
7
2023
58
0.560
 Why?
Hospitalization
2
2010
210
0.550
 Why?
Quality of Life
5
2019
140
0.550
 Why?
Respiratory Tract Diseases
2
2007
7
0.550
 Why?
Physician's Role
2
2008
7
0.540
 Why?
Tranexamic Acid
1
2015
1
0.520
 Why?
Bradykinin
1
2015
5
0.520
 Why?
Cetirizine
3
2004
4
0.520
 Why?
Nebulizers and Vaporizers
6
2021
8
0.520
 Why?
Respiratory Hypersensitivity
5
2008
6
0.510
 Why?
Patient Compliance
3
2010
55
0.510
 Why?
Adult
12
2020
1181
0.500
 Why?
School Health Services
1
2014
9
0.480
 Why?
Immune System Diseases
1
2014
6
0.480
 Why?
Referral and Consultation
3
2019
32
0.480
 Why?
Administration, Inhalation
6
2023
19
0.480
 Why?
Anti-Allergic Agents
3
2004
6
0.480
 Why?
Emergency Service, Hospital
3
2022
130
0.470
 Why?
Videoconferencing
3
2019
5
0.460
 Why?
Case Management
3
2010
3
0.450
 Why?
Treatment Outcome
10
2012
622
0.430
 Why?
Emergency Medical Services
2
2010
14
0.430
 Why?
Medication Adherence
1
2012
21
0.430
 Why?
Severity of Illness Index
6
2019
149
0.420
 Why?
Complex Mixtures
1
2012
1
0.420
 Why?
Parent-Child Relations
1
2012
37
0.420
 Why?
Pets
1
2012
1
0.410
 Why?
Serologic Tests
1
2011
3
0.400
 Why?
Counseling
2
2009
28
0.400
 Why?
Practice Patterns, Physicians'
3
2013
85
0.390
 Why?
Antibodies, Monoclonal
4
2006
23
0.380
 Why?
Dermatitis, Atopic
5
2013
7
0.370
 Why?
Community Health Services
2
2010
7
0.360
 Why?
Immunization
3
2020
25
0.360
 Why?
Decision Making, Computer-Assisted
2
2020
2
0.360
 Why?
Air Pollution
2
2019
4
0.360
 Why?
Health Maintenance Organizations
1
2009
1
0.330
 Why?
Family Practice
1
2009
4
0.330
 Why?
School Nursing
1
2009
5
0.330
 Why?
Time Factors
7
2019
250
0.330
 Why?
Environmental Illness
2
2007
2
0.330
 Why?
Status Asthmaticus
2
2003
2
0.320
 Why?
Risk Assessment
3
2019
137
0.310
 Why?
Age Factors
5
2019
210
0.310
 Why?
Clinical Trials as Topic
5
2016
45
0.310
 Why?
Missouri
6
2017
81
0.300
 Why?
Schools
2
2020
56
0.300
 Why?
Guideline Adherence
3
2010
36
0.300
 Why?
Humidity
1
2007
3
0.290
 Why?
Histamine H1 Antagonists, Non-Sedating
2
2004
3
0.290
 Why?
Meteorological Concepts
2
2004
3
0.290
 Why?
Colony Count, Microbial
4
2014
4
0.290
 Why?
Vaccines
4
2012
17
0.290
 Why?
Infant
10
2016
1446
0.280
 Why?
Terfenadine
2
2003
2
0.280
 Why?
Government Programs
1
2006
4
0.280
 Why?
Health Plan Implementation
1
2006
9
0.270
 Why?
Medical History Taking
2
2003
4
0.270
 Why?
Surveys and Questionnaires
3
2023
274
0.270
 Why?
Life Style
1
2006
24
0.260
 Why?
Asthma, Exercise-Induced
3
2016
3
0.260
 Why?
Program Evaluation
3
2019
45
0.260
 Why?
Prevalence
5
2016
146
0.260
 Why?
Middle Aged
4
2019
608
0.260
 Why?
Seasons
3
2011
35
0.250
 Why?
Insurance, Health
2
2019
16
0.250
 Why?
Histamine H1 Antagonists
1
2004
5
0.250
 Why?
Family Health
1
2004
14
0.250
 Why?
Tobacco Smoke Pollution
2
2014
5
0.240
 Why?
Immunoenzyme Techniques
3
2006
9
0.230
 Why?
Precision Medicine
1
2024
45
0.230
 Why?
Immunoblotting
4
2002
11
0.230
 Why?
Sleep Stages
1
2003
1
0.230
 Why?
Arthropod Venoms
2
2019
2
0.230
 Why?
Information Services
1
2003
1
0.230
 Why?
Antigens, Plant
3
2017
3
0.230
 Why?
Diagnosis, Computer-Assisted
1
2023
4
0.220
 Why?
Double-Blind Method
7
2020
44
0.220
 Why?
Powders
1
2023
1
0.220
 Why?
Single-Blind Method
3
2009
12
0.210
 Why?
Plant Proteins
2
2018
3
0.210
 Why?
Documentation
1
2022
6
0.210
 Why?
Injections, Subcutaneous
1
2022
8
0.210
 Why?
Phobic Disorders
1
2022
4
0.210
 Why?
Attitude
1
2022
10
0.210
 Why?
Hospitals, Pediatric
1
2003
187
0.200
 Why?
Chronic Disease
2
2020
105
0.200
 Why?
Poaceae
2
2017
2
0.200
 Why?
Trees
2
2017
2
0.200
 Why?
Climate
2
2019
4
0.200
 Why?
Antibodies, Fungal
3
2017
3
0.200
 Why?
Mass Screening
1
2021
35
0.200
 Why?
Bronchiolitis, Viral
2
1993
4
0.190
 Why?
Nomograms
1
2020
1
0.180
 Why?
ROC Curve
1
2020
22
0.180
 Why?
Adaptive Immunity
2
2017
5
0.180
 Why?
Videotape Recording
1
2020
3
0.180
 Why?
Triage
1
2020
4
0.180
 Why?
Retrospective Studies
6
2014
1296
0.180
 Why?
Urticaria
2
2014
2
0.180
 Why?
Cross-Sectional Studies
2
2019
336
0.180
 Why?
General Practice
1
2019
1
0.180
 Why?
Immunologic Deficiency Syndromes
2
2020
9
0.180
 Why?
Ambulatory Care Facilities
1
2020
36
0.170
 Why?
Nasal Obstruction
2
2017
3
0.170
 Why?
Lymphoma, T-Cell
1
2019
2
0.170
 Why?
Glucocorticoids
1
2020
32
0.170
 Why?
Aged
2
2019
378
0.170
 Why?
Patient Participation
1
2019
15
0.170
 Why?
Polyethylene Glycols
1
2019
9
0.170
 Why?
Asparaginase
1
2019
13
0.170
 Why?
Young Adult
2
2019
647
0.170
 Why?
Computer-Assisted Instruction
1
2019
3
0.170
 Why?
Congresses as Topic
1
2019
9
0.170
 Why?
User-Computer Interface
1
2019
11
0.170
 Why?
Fellowships and Scholarships
1
2019
17
0.170
 Why?
Cost-Benefit Analysis
1
2019
25
0.170
 Why?
Self Administration
1
2019
2
0.170
 Why?
Curriculum
1
2019
22
0.170
 Why?
Drug Combinations
1
2019
19
0.170
 Why?
Self Concept
1
2019
8
0.170
 Why?
Family Characteristics
1
2019
10
0.170
 Why?
Mitosporic Fungi
2
1990
2
0.170
 Why?
Weather
1
2019
4
0.170
 Why?
Antineoplastic Agents
1
2019
55
0.170
 Why?
Climate Change
1
2019
2
0.170
 Why?
Educational Status
1
2019
21
0.170
 Why?
Income
1
2019
17
0.170
 Why?
Multivariate Analysis
1
2019
71
0.160
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2019
52
0.160
 Why?
Biological Products
1
2018
3
0.160
 Why?
Longitudinal Studies
1
2019
119
0.160
 Why?
Penicillin G
1
2018
1
0.160
 Why?
Penicillins
1
2018
8
0.160
 Why?
Licensure, Medical
1
2018
1
0.160
 Why?
Medical Staff Privileges
1
2018
1
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
6
1996
24
0.160
 Why?
Respiratory Function Tests
3
2006
16
0.160
 Why?
Mycoses
3
2006
12
0.160
 Why?
Consensus
2
2023
35
0.160
 Why?
Temperature
2
2011
12
0.160
 Why?
Randomized Controlled Trials as Topic
4
2017
55
0.150
 Why?
Advisory Committees
2
2015
9
0.150
 Why?
Cats
2
2012
4
0.150
 Why?
RNA, Messenger
1
1998
115
0.150
 Why?
Dogs
2
2012
17
0.150
 Why?
Pathogen-Associated Molecular Pattern Molecules
1
2017
1
0.150
 Why?
Receptors, Pattern Recognition
1
2017
1
0.150
 Why?
Risk Factors
3
2020
487
0.150
 Why?
Particulate Matter
1
2017
1
0.150
 Why?
Cities
1
2017
10
0.140
 Why?
Venoms
1
2017
2
0.140
 Why?
Reproducibility of Results
3
2015
199
0.140
 Why?
Injections
1
2017
5
0.140
 Why?
Glycoproteins
2
2013
9
0.140
 Why?
Bronchoconstriction
1
2016
1
0.140
 Why?
Follow-Up Studies
2
2009
304
0.140
 Why?
Patient Safety
1
2016
20
0.140
 Why?
Recombinant Fusion Proteins
1
1996
13
0.130
 Why?
Diagnosis, Differential
4
2010
77
0.130
 Why?
Socioeconomic Factors
3
2015
53
0.130
 Why?
Bacteria
1
2015
9
0.130
 Why?
Societies, Medical
2
2014
51
0.130
 Why?
Antibodies
2
1993
15
0.130
 Why?
Poverty
1
2015
27
0.130
 Why?
Dermatitis, Contact
1
2015
1
0.130
 Why?
Rhinitis
2
2008
3
0.130
 Why?
Ambulatory Care
1
2015
45
0.130
 Why?
Terbutaline
2
2020
2
0.120
 Why?
Patient Care Planning
1
2014
1
0.120
 Why?
Sympathomimetics
1
2014
2
0.120
 Why?
Infant, Newborn
2
2016
816
0.120
 Why?
Immunologic Techniques
1
2014
1
0.120
 Why?
Adrenergic beta-2 Receptor Agonists
1
2014
1
0.120
 Why?
Drug Therapy, Combination
2
2017
35
0.120
 Why?
Caregivers
1
2014
40
0.120
 Why?
Primary Prevention
1
2013
2
0.120
 Why?
Vaccination
2
2012
71
0.120
 Why?
Spirometry
3
2008
7
0.110
 Why?
Interferon-alpha
1
1993
2
0.110
 Why?
Sensitivity and Specificity
2
2011
150
0.110
 Why?
Hereditary Angioedema Types I and II
1
2013
1
0.110
 Why?
Risk
3
2019
41
0.110
 Why?
Respiratory Syncytial Virus, Human
1
1993
27
0.110
 Why?
Recombinant Proteins
2
2008
48
0.110
 Why?
Disease Reservoirs
1
2012
1
0.110
 Why?
Food Contamination
1
2012
1
0.110
 Why?
Pest Control
1
2012
1
0.110
 Why?
Rodentia
1
2012
1
0.110
 Why?
Respiratory Syncytial Virus Infections
1
1993
50
0.110
 Why?
Prognosis
2
2019
211
0.110
 Why?
United States Food and Drug Administration
1
2012
4
0.110
 Why?
Health Care Costs
2
2010
33
0.110
 Why?
Sneezing
3
2009
3
0.100
 Why?
Expert Testimony
1
2012
3
0.100
 Why?
Acquired Immunodeficiency Syndrome
1
1992
2
0.100
 Why?
Urban Population
2
2015
27
0.100
 Why?
Observer Variation
2
2002
16
0.100
 Why?
Methotrexate
1
1992
30
0.100
 Why?
Kansas
3
2014
43
0.100
 Why?
Adjuvants, Immunologic
2
2008
2
0.100
 Why?
Carbohydrates
1
1991
2
0.100
 Why?
Ambrosia
1
2011
1
0.100
 Why?
Quality Assurance, Health Care
2
2017
7
0.100
 Why?
Parents
1
2012
157
0.090
 Why?
Egg Hypersensitivity
1
2011
2
0.090
 Why?
Administration, Intranasal
4
2017
8
0.090
 Why?
Decision Making
2
2015
23
0.090
 Why?
Aerosols
2
2003
4
0.090
 Why?
Health Planning Guidelines
1
2010
2
0.090
 Why?
Influenza Vaccines
1
2011
28
0.090
 Why?
Managed Care Programs
1
2010
3
0.090
 Why?
Quality Control
2
2000
8
0.090
 Why?
Phthalazines
1
2009
1
0.090
 Why?
Sucrose
1
2009
1
0.090
 Why?
Sweetening Agents
1
2009
1
0.090
 Why?
Candidiasis, Chronic Mucocutaneous
1
1989
1
0.090
 Why?
Candidiasis
1
1989
5
0.090
 Why?
Air Conditioning
1
2009
1
0.090
 Why?
Comparative Effectiveness Research
1
2009
6
0.090
 Why?
Electrophoresis, Polyacrylamide Gel
3
1993
9
0.080
 Why?
Cooperative Behavior
1
2009
24
0.080
 Why?
Vaccines, DNA
1
2008
1
0.080
 Why?
Bacterial Vaccines
1
2008
2
0.080
 Why?
Registries
1
2009
92
0.080
 Why?
Program Development
2
2010
12
0.080
 Why?
Respirovirus Infections
1
1988
1
0.080
 Why?
Ergosterol
1
2008
1
0.080
 Why?
Glucans
1
2008
1
0.080
 Why?
Irritants
1
2008
1
0.080
 Why?
Interferon Type I
1
1988
5
0.080
 Why?
Albuterol
3
2020
5
0.080
 Why?
Antibody Specificity
2
2001
8
0.080
 Why?
Allied Health Personnel
1
2007
1
0.070
 Why?
Sick Building Syndrome
1
2007
1
0.070
 Why?
Blotting, Northern
2
1998
4
0.070
 Why?
Molecular Sequence Data
2
1998
71
0.070
 Why?
Base Sequence
2
1998
81
0.070
 Why?
Genetic Predisposition to Disease
1
2008
231
0.070
 Why?
Immunoglobulin G
2
2002
34
0.070
 Why?
Massachusetts
1
2006
2
0.070
 Why?
Patient Selection
2
2010
40
0.070
 Why?
Community-Institutional Relations
1
2006
5
0.070
 Why?
Social Work
1
2006
3
0.070
 Why?
Research Support as Topic
1
2006
6
0.070
 Why?
Patient Admission
1
2006
9
0.070
 Why?
Health Services Needs and Demand
1
2006
15
0.070
 Why?
Leukotriene Antagonists
2
2017
6
0.070
 Why?
Drug Utilization
1
2006
15
0.070
 Why?
Psychophysiologic Disorders
1
1986
3
0.070
 Why?
Aspergillus
2
2017
2
0.070
 Why?
Cladosporium
2
2017
2
0.070
 Why?
Penicillium
2
2017
2
0.070
 Why?
Mice, Inbred BALB C
2
1998
29
0.070
 Why?
Bronchoalveolar Lavage
1
2006
2
0.070
 Why?
Early Diagnosis
1
2006
17
0.070
 Why?
Sinusitis
1
2005
5
0.070
 Why?
Combined Modality Therapy
1
2006
46
0.070
 Why?
Air
1
2005
2
0.060
 Why?
Health Status
1
2005
25
0.060
 Why?
Decontamination
1
2005
1
0.060
 Why?
Cerebrospinal Fluid
1
1985
8
0.060
 Why?
Mice
2
1998
348
0.060
 Why?
Attitude to Health
1
2004
26
0.060
 Why?
Patient-Centered Care
1
2004
16
0.060
 Why?
Mycology
1
2004
2
0.060
 Why?
Product Surveillance, Postmarketing
1
2004
1
0.060
 Why?
Conditioning, Operant
1
2003
2
0.060
 Why?
Costs and Cost Analysis
1
2003
5
0.060
 Why?
Delphi Technique
1
2023
11
0.060
 Why?
Clinical Decision-Making
1
2023
17
0.060
 Why?
Health Resources
1
2003
17
0.060
 Why?
Automobile Driving
1
2003
5
0.060
 Why?
Drug Prescriptions
1
2003
20
0.060
 Why?
Particle Size
1
2003
2
0.060
 Why?
Forecasting
1
2023
22
0.060
 Why?
Prednisone
2
1994
12
0.060
 Why?
Hospital Costs
1
2003
29
0.060
 Why?
False Negative Reactions
1
2003
9
0.060
 Why?
False Positive Reactions
1
2003
4
0.060
 Why?
Public Health
1
2003
18
0.060
 Why?
Attitude of Health Personnel
1
2003
42
0.060
 Why?
Predictive Value of Tests
1
2003
99
0.050
 Why?
Occupational Exposure
1
2003
1
0.050
 Why?
Databases, Factual
1
2003
108
0.050
 Why?
Emergencies
1
2003
11
0.050
 Why?
Alkaline Phosphatase
2
1993
18
0.050
 Why?
Military Medicine
1
2002
1
0.050
 Why?
Insurance Selection Bias
1
2002
1
0.050
 Why?
Bronchial Hyperreactivity
1
2002
7
0.050
 Why?
Unnecessary Procedures
1
2002
13
0.050
 Why?
Airway Obstruction
1
2002
20
0.050
 Why?
Medicine
1
2002
10
0.050
 Why?
Molecular Weight
1
2002
2
0.050
 Why?
Insurance Coverage
1
2002
21
0.050
 Why?
Electronic Health Records
1
2023
64
0.050
 Why?
Recurrence
1
2002
110
0.050
 Why?
Drug Administration Routes
1
2001
3
0.050
 Why?
Time
1
2001
6
0.050
 Why?
Animals, Domestic
1
2001
1
0.050
 Why?
Mites
1
2001
1
0.050
 Why?
Inhalation Exposure
1
2001
1
0.050
 Why?
Insect Proteins
1
2001
2
0.050
 Why?
Species Specificity
1
2001
10
0.050
 Why?
Immunoassay
1
2001
10
0.050
 Why?
Anti-Bacterial Agents
3
2004
243
0.050
 Why?
Conjunctivitis
1
2001
1
0.050
 Why?
Biomedical Technology
1
2021
5
0.050
 Why?
Urban Health
1
2001
3
0.050
 Why?
Circadian Rhythm
1
2001
7
0.050
 Why?
Physical Examination
1
2001
5
0.050
 Why?
Pregnancy
1
2001
216
0.040
 Why?
Pilot Projects
2
1992
120
0.040
 Why?
Hemorrhage
1
1999
19
0.040
 Why?
Lung Diseases
1
1999
23
0.040
 Why?
Nasal Mucosa
2
2003
8
0.040
 Why?
Dose-Response Relationship, Immunologic
1
2018
1
0.040
 Why?
Acute Disease
2
2014
79
0.040
 Why?
Gastrointestinal Diseases
1
2018
45
0.040
 Why?
Physician-Patient Relations
1
2017
17
0.040
 Why?
Chaetomium
1
2017
1
0.040
 Why?
Mupirocin
1
1996
3
0.040
 Why?
Methicillin Resistance
1
1996
3
0.040
 Why?
Vacuum
1
2016
1
0.040
 Why?
Evaluation Studies as Topic
1
1996
8
0.040
 Why?
Cross Infection
1
1996
12
0.040
 Why?
Staphylococcus aureus
1
1996
18
0.040
 Why?
Staphylococcal Infections
1
1996
21
0.040
 Why?
DNA, Complementary
1
1996
9
0.030
 Why?
RNA
1
1996
14
0.030
 Why?
Amino Acid Sequence
1
1996
32
0.030
 Why?
Drug Administration Schedule
1
1996
35
0.030
 Why?
Syndrome
1
2016
34
0.030
 Why?
Genes, Bacterial
1
2015
1
0.030
 Why?
Protein Array Analysis
1
2015
4
0.030
 Why?
Microbiota
1
2015
8
0.030
 Why?
RNA, Ribosomal, 16S
1
2015
9
0.030
 Why?
Phylogeny
1
2015
24
0.030
 Why?
Regression Analysis
1
2015
52
0.030
 Why?
C-Reactive Protein
1
1995
16
0.030
 Why?
Forced Expiratory Volume
2
1992
10
0.030
 Why?
Cystic Fibrosis
1
1995
18
0.030
 Why?
Primary Health Care
1
2015
42
0.030
 Why?
Air Filters
1
2014
1
0.030
 Why?
Filtration
1
2014
2
0.030
 Why?
Astemizole
1
1994
1
0.030
 Why?
Premedication
1
1994
2
0.030
 Why?
Ranitidine
1
1994
5
0.030
 Why?
Odds Ratio
1
2014
51
0.030
 Why?
Immunization Schedule
1
1994
10
0.030
 Why?
Sulfides
1
2014
6
0.030
 Why?
Cyclopropanes
1
2014
7
0.030
 Why?
Acetates
1
2014
5
0.030
 Why?
Quinolines
1
2014
6
0.030
 Why?
Epitopes
1
1993
20
0.030
 Why?
Nasal Lavage Fluid
1
1993
1
0.030
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2013
15
0.030
 Why?
Adsorption
1
1993
1
0.030
 Why?
Horseradish Peroxidase
1
1993
1
0.030
 Why?
Electrophoresis, Gel, Two-Dimensional
1
1993
1
0.030
 Why?
Buffers
1
1993
2
0.030
 Why?
Protease Inhibitors
1
1993
2
0.030
 Why?
Indicators and Reagents
1
1993
4
0.030
 Why?
Arthropod Proteins
1
2013
1
0.030
 Why?
Cysteine Endopeptidases
1
2013
3
0.030
 Why?
Glycoside Hydrolases
1
1993
2
0.030
 Why?
Rabbits
1
1993
5
0.030
 Why?
Microbiological Techniques
1
1993
5
0.030
 Why?
Patient Care
1
2013
6
0.030
 Why?
Case-Control Studies
1
2013
215
0.030
 Why?
Meta-Analysis as Topic
1
2012
14
0.030
 Why?
Respiratory Tract Infections
1
2014
85
0.030
 Why?
Chest Pain
1
1992
3
0.030
 Why?
Hypersensitivity, Delayed
1
1992
2
0.030
 Why?
Maximal Expiratory Flow Rate
1
1992
1
0.030
 Why?
Theophylline
1
1992
2
0.030
 Why?
Beclomethasone
1
1992
2
0.030
 Why?
Vital Capacity
1
1992
6
0.030
 Why?
Cromolyn Sodium
1
1992
3
0.030
 Why?
History, 20th Century
1
1992
6
0.030
 Why?
Body Height
1
1992
34
0.030
 Why?
Canada
1
1992
31
0.030
 Why?
Body Weight
1
1992
52
0.030
 Why?
Chromatography
1
1991
1
0.020
 Why?
Sepharose
1
1991
2
0.020
 Why?
Phenols
1
1991
7
0.020
 Why?
Europe
1
2011
37
0.020
 Why?
Steroids
1
2011
16
0.020
 Why?
North America
1
2011
44
0.020
 Why?
Bronchial Spasm
1
2010
1
0.020
 Why?
Drug Therapy
1
2010
7
0.020
 Why?
Chromatography, Affinity
1
1990
2
0.020
 Why?
Michigan
1
2010
2
0.020
 Why?
Health Care Rationing
1
2010
3
0.020
 Why?
Patient Advocacy
1
2010
5
0.020
 Why?
Dysgammaglobulinemia
1
1989
1
0.020
 Why?
IgG Deficiency
1
1989
1
0.020
 Why?
Immunoglobulin M
1
1989
5
0.020
 Why?
Candida albicans
1
1989
4
0.020
 Why?
Drug Design
1
2009
7
0.020
 Why?
Health Knowledge, Attitudes, Practice
1
2010
65
0.020
 Why?
Aged, 80 and over
1
2009
151
0.020
 Why?
Dose-Response Relationship, Drug
1
2009
94
0.020
 Why?
Partial Pressure
1
1988
1
0.020
 Why?
Pulse
1
1988
1
0.020
 Why?
Biological Assay
1
1988
3
0.020
 Why?
Respiration
1
1988
5
0.020
 Why?
Immunologic Tests
1
2008
1
0.020
 Why?
Dermatitis, Allergic Contact
1
2008
1
0.020
 Why?
Lung Diseases, Obstructive
1
2008
3
0.020
 Why?
Critical Care
1
1988
13
0.020
 Why?
Diagnostic Techniques and Procedures
1
2008
5
0.020
 Why?
Carbon Dioxide
1
1988
14
0.020
 Why?
Immunity, Cellular
1
2008
18
0.020
 Why?
Respiratory Syncytial Viruses
1
1988
18
0.020
 Why?
Inflammation
1
2008
51
0.020
 Why?
Cross Reactions
1
2006
8
0.020
 Why?
Spinal Puncture
1
1985
1
0.020
 Why?
Child Abuse
1
1986
46
0.020
 Why?
Leukocyte Count
1
1985
6
0.020
 Why?
Monocytes
1
1985
9
0.020
 Why?
Neutrophils
1
1985
11
0.020
 Why?
Seizures
1
1985
25
0.020
 Why?
Dermatitis, Irritant
1
2004
1
0.020
 Why?
Calcineurin Inhibitors
1
2004
2
0.020
 Why?
Phototherapy
1
2004
2
0.020
 Why?
Emollients
1
2004
2
0.020
 Why?
Skin Diseases, Infectious
1
2004
2
0.020
 Why?
Administration, Cutaneous
1
2004
4
0.020
 Why?
Anti-Inflammatory Agents
1
2004
11
0.020
 Why?
Hemodynamics
1
2003
10
0.010
 Why?
Electrocardiography
1
2003
14
0.010
 Why?
Therapeutic Equivalency
1
2001
5
0.010
 Why?
Suburban Population
1
1999
1
0.010
 Why?
Drug Resistance, Microbial
1
1996
2
0.010
 Why?
Infection Control
1
1996
7
0.010
 Why?
Physical Therapy Modalities
1
1995
4
0.010
 Why?
Fluid Therapy
1
1995
17
0.010
 Why?
Peak Expiratory Flow Rate
1
1992
1
0.010
 Why?
Incidence
1
1992
133
0.010
 Why?
Portnoy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (535) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_